Belharra Therapeutics · 19 hours ago
Research Assistant, Compound Management (Part-Time Temporary)
Belharra Therapeutics is an early-stage small molecule discovery company focused on innovative drug discovery methods. They are seeking a reliable individual for a part-time temporary contract position in Compound Management to support multidisciplinary drug discovery efforts by providing comprehensive compound logistics support.
BiotechnologyChemicalTherapeutics
Responsibilities
Works independently to manage routine activities: receive and process compound requests to support projects as well as external collaboration including packing, labeling, and maintain proper documentation
Logistical support for project teams including documentation management, shipping/ receiving of disposables and compounds
Weighing, dissolution, compound storage/retrieval
Operation of laboratory automation and liquid handlers to fulfill requests
Prepare acoustic dispensed assay ready compound plates
Support high-throughput screening and lead profiling efforts
Troubleshooting and recovery of instrumentation errors
Adhere to EHS standards for laboratory safety, including proper use of personal protective equipment and proper operation of safety enclosures and other equipment
Qualification
Required
Current enrollment in a bachelor's degree program in a relevant life sciences field
Strong organizational skills
Attention to detail
Ability to communicate effectively with project stakeholders
Ability to operate independently and maintain high-quality standards
Good multi-tasking skills
Record keeping skills
Ability to work effectively in an interdisciplinary, team-oriented, collaborative, high performance environment
Demonstrated troubleshooting and problem-solving skills
Collaborative, flexible and proactive
Proficient in Microsoft Office
Preferred
Bachelor's degree in chemistry or related life sciences degree
Previous compound management experience
Company
Belharra Therapeutics
Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.
Funding
Current Stage
Growth StageTotal Funding
$50MKey Investors
Versant Ventures
2023-01-04Series A· $50M
Recent News
2024-12-10
Company data provided by crunchbase